INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASE SUPPRESS LIPOPOLYSACCHARIDE-INDUCED NITRITE FORMATION IN MACROPHAGES

被引:38
|
作者
HAUSCHILDT, S
SCHEIPERS, P
BESSLER, WG
机构
[1] Institute of Immunobiology, University of Freiburg
关键词
D O I
10.1016/0006-291X(91)91898-M
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Stimulating bone marrow derived macrophages with LPS results in the induction of NO-synthase as measured by NO2- formation. Inhibitors of poly(ADP-ribose)polymerase, namely nicotinamide, 3-aminobenzamide and 3-methoxybenzamide, prevented NO2- formation in a dose dependent manner. Inhibition was most effective if the inhibitors were added at the same time as LPS. When added 10h after exposure to LPS, a time at which expression of the enzyme had reached its maximum, no inhibition was observed. The inhibitors also blocked early events in activation such as protein and RNA-synthesis as well as DNA-synthesis. Thus prevention of NO2- formation may be related to inhibition of these events. Activation of macrophages by LPS was not accompanied by an increase but rather by a small decrease in ADP-ribosyltransferase activity. Whether this decrease plays a physiological role in activation needs further exploration. © 1991.
引用
收藏
页码:865 / 871
页数:7
相关论文
共 50 条
  • [21] Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Urothelial Cancer
    Gamba, Teresa
    Paparo, Jessica
    Panepinto, Olimpia
    Dionisio, Rossana
    Di Maio, Massimo
    Vignani, Francesca
    CLINICAL GENITOURINARY CANCER, 2023, 21 (05) : 509 - 516
  • [22] Inhibition of efflux transporters by poly ADP-ribose polymerase inhibitors
    Deng, Feng
    Sistonen, Johanna
    Neuvonen, Mikko
    Niemi, Mikko
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2023, 132 : 6 - 7
  • [23] FURTHER-STUDIES ON INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASE
    GEORGE, AM
    WILSON, I
    WHISH, WJD
    CRAMP, WA
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1985, 47 (02) : 223 - 223
  • [24] Natural Inhibitors of Poly(ADP-ribose) Polymerase-1
    Banasik, Marek
    Stedeford, Todd
    Strosznajder, Robert P.
    MOLECULAR NEUROBIOLOGY, 2012, 46 (01) : 55 - 63
  • [25] LOSS OF AMPLIFIED GENES BY POLY(ADP-RIBOSE) POLYMERASE INHIBITORS
    NAGAO, M
    NAKAYASU, M
    AONUMA, S
    SHIMA, H
    SUGIMURA, T
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1991, 93 : 169 - 174
  • [26] Poly(ADP-ribose) polymerase inhibitors as promising cancer therapeutics
    He, Jin-xue
    Yang, Chun-hao
    Miao, Ze-hong
    ACTA PHARMACOLOGICA SINICA, 2010, 31 (09) : 1172 - 1180
  • [27] Poly(ADP-ribose) polymerase (PARP) inhibitors and ovarian cancer
    Liu, Chia-Hao
    Chang, Yi
    Wang, Peng-Hui
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2017, 56 (05): : 713 - 714
  • [28] Novel poly(ADP-ribose) polymerase-1 inhibitors
    Dunn, Derek
    Husten, Jean
    Ator, Mark A.
    Chatterjee, Sankar
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (02) : 542 - 545
  • [29] POTENTIATION OF THE ACTION OF DTIC BY INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASE
    LUNN, JM
    PIERPOINT, C
    GOLDING, BT
    HARRIS, AL
    BRITISH JOURNAL OF CANCER, 1985, 52 (03) : 439 - 440
  • [30] Poly(ADP-ribose) polymerase inhibitors as promising cancer therapeutics
    Jin-xue He
    Chun-hao Yang
    Ze-hong Miao
    Acta Pharmacologica Sinica, 2010, 31 : 1172 - 1180